Seagen (formerly Seattle Genetics) is a biotechnology company focused on developing innovative therapies for the treatment of cancer. The company, headquartered in Bothell, Washington, is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. TUKYSA® is indicated for the treatment of adult patients with advanced metastatic HER2-positive breast cancer. While at Alexander Health, I designed print and digital pieces, including banner ads, brochures, and CVAs, for both clinical and consumer audiences.
